What the evidence says. Strong cell and animal data and decades of cosmetic use, but human evidence is limited to a few small, often industry-linked skin and wound studies with mixed objective results; injected use has no human trials at all. (Preliminary evidence: Early or small human trials; promising but not yet conclusive.)
What is GHK-Cu (Copper Peptide)?
GHK-Cu (Copper Peptide) (Glycyl-L-histidyl-L-lysine copper complex) is a joint and skin supplement used for may modestly improve skin texture and fine lines (small, often industry-run studies). NutriDex grades the human evidence as Preliminary. GHK is a tiny three-amino-acid peptide found naturally in blood, saliva and urine. It binds copper tightly, and the GHK-Cu complex has been used in skincare since the 1990s. In cell and animal studies it boosts collagen and elastin, blood-vessel growth and wound repair, and alters the activity of many genes. Human evidence is much thinner. A 1994 randomised trial found faster healing of diabetic foot ulcers with a copper-peptide gel, and cosmetic studies report smoother skin and fewer fine lines, but many are small, unpublished or company-run. A 13-person randomised trial after laser resurfacing found no objective benefit, and recent reviews call GHK-Cu promising but unproven, partly because it penetrates skin poorly. Injecting 'research-grade' GHK-Cu for whole-body anti-aging has no human trials; FDA listed injectable GHK-Cu among compounding substances with safety concerns in 2023 and removed it from that list in April 2026 without approving it.
Purported Benefits
✓May modestly improve skin texture and fine lines (small, often industry-run studies)
✓Promotes collagen production and wound repair in lab and animal models
✓Faster diabetic ulcer healing in one early randomised trial
✓Included in hair-growth formulas (weak, mixed human data)
✓(Claimed, unproven) whole-body anti-aging and tissue repair when injected
Dosing & Compounds
Typical Dose
Topical: used in cosmetic serums and creams as directed on the product. There is no established safe human dose for injected GHK-Cu, which is not an approved drug.
Active Compounds
GHK (glycyl-L-histidyl-L-lysine) tripeptideCopper(II) bound to GHKPalmitoyl tripeptide-1 (Pal-GHK, a copper-free cosmetic analogue)
Safety & Cautions
⚠
Topical GHK-Cu is generally well tolerated, though irritation or contact dermatitis can occur; patch-test new products. Injectable GHK-Cu is an unapproved drug: 'research use' vials have unverified purity, sterility and copper content, and there are no human data on systemic safety, copper loading, or effects on existing tumours given its pro-angiogenic activity in the lab. People with Wilson disease or other copper-handling disorders, and anyone pregnant, should avoid injected copper products. Educational only — always check with your doctor or pharmacist before combining GHK-Cu (Copper Peptide) with any medicine.
GHK-Cu (Copper Peptide) is most often taken for May modestly improve skin texture and fine lines (small, often industry-run studies), Promotes collagen production and wound repair in lab and animal models, Faster diabetic ulcer healing in one early randomised trial, Included in hair-growth formulas (weak, mixed human data). Skincare copper peptide with thin human data; injecting is unproven
Does GHK-Cu (Copper Peptide) work — what does the evidence say?
Preliminary evidence. Early or small human trials; promising but not yet conclusive. GHK is a tiny three-amino-acid peptide found naturally in blood, saliva and urine. It binds copper tightly, and the GHK-Cu complex has been used in skincare since the 1990s. In cell and animal studies it boosts collagen and elastin, blood-vessel growth and wound repair, and alters the activity of many genes. Human evidence is much thinner. A 1994 randomised trial found faster healing of diabetic foot ulcers with a copper-peptide gel, and cosmetic studies report smoother skin and fewer fine lines, but many are small, unpublished or company-run. A 13-person randomised trial after laser resurfacing found no objective benefit, and recent reviews call GHK-Cu promising but unproven, partly because it penetrates skin poorly. Injecting 'research-grade' GHK-Cu for whole-body anti-aging has no human trials; FDA listed injectable GHK-Cu among compounding substances with safety concerns in 2023 and removed it from that list in April 2026 without approving it.
What is the typical dose of GHK-Cu (Copper Peptide)?
Topical: used in cosmetic serums and creams as directed on the product. There is no established safe human dose for injected GHK-Cu, which is not an approved drug.
Is GHK-Cu (Copper Peptide) safe? Any cautions or side effects?
Topical GHK-Cu is generally well tolerated, though irritation or contact dermatitis can occur; patch-test new products. Injectable GHK-Cu is an unapproved drug: 'research use' vials have unverified purity, sterility and copper content, and there are no human data on systemic safety, copper loading, or effects on existing tumours given its pro-angiogenic activity in the lab. People with Wilson disease or other copper-handling disorders, and anyone pregnant, should avoid injected copper products.
How many studies support GHK-Cu (Copper Peptide)?
NutriDex cites 10 sources for GHK-Cu (Copper Peptide), graded "Preliminary".
Cite this page
APA
Peh, D. (2026). GHK-Cu (Copper Peptide) (Glycyl-L-histidyl-L-lysine copper complex): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 18 Oct 2026, from https://nutridex.info/s/ghk-cu
BibTeX
@misc{nutridex_ghk_cu,
author = {Peh, Daryl},
title = {GHK-Cu (Copper Peptide) (Glycyl-L-histidyl-L-lysine copper complex): Benefits, Dosage, Side Effects \& Evidence},
year = {2026},
howpublished = {NutriDex --- The Supplement Research Compendium},
url = {https://nutridex.info/s/ghk-cu},
note = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-10-18}
}
For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.